Taysha Gene Therapies, Inc. — SCHEDULE 13G Filings
2 SCHEDULE 13G filings on record
This page lists all SCHEDULE 13G filings submitted to the SEC by Taysha Gene Therapies, Inc. (TSHA), sorted by most recent first. Each row links to the full filing on EdgarLookup. Taysha Gene Therapies, Inc. has filed 2 SCHEDULE 13G documents with the SEC since 2020. To view all SEC filings by Taysha Gene Therapies, Inc., see the full filings list.
All
10-K
10-K/A
10-Q
144
144/A
3
4
4/A
424B3
424B4
424B5
5
8-A12B
8-K
8-K/A
ARS
CERT
CORRESP
D
DEF 14A
DEFA14A
DEFR14A
DRS
EFFECT
PRE 14A
S-1
S-1/A
S-1MEF
S-3
S-3ASR
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| SCHEDULE 13G | — | 0000902664-26-001081 | Feb 17, 2026 | — |
| SCHEDULE 13G | — | 0001214659-25-002035 | Feb 5, 2025 | — |